Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

At the five-year celebration event, scientists and health study volunteers from across the DPUK partnership came together to launch one of the world’s most in-depth study's into preclinical Alzheimer’s disease - one of the most important outcomes from DPUK's work to transform dementia research infrastructure in the UK.

The event saw scientists from each of the major research networks in Dementias Platform UK (DPUK) – Imaging, Stem Cells and Informatics – come together with many of the lead researchers of large clinical studies into dementia. The Deep and Frequent Phenotyping study which is about to launch, is an example of one such study, which aims to pinpoint the signs of dementia much earlier in the disease development.

Dementia affects over 50 million people worldwide and is the biggest public health crisis facing us in the 21st century. We have stepped up the fights against it with this multi-million pound investment. Whilst the money is crucial, what is also important with a programme of this kind is that what it can achieve is greater than the sum of its parts.
- Professor John Gallacher, Director of Dementias Platform UK.

 

Read more here.

 

 

Similar stories

New Research Highlights Importance of Early Years Development on Future Wellbeing

Oxford researchers involved nearly 4,000 children across the UK in three specially developed science lessons to educate pupils about brain development during early childhood. The SEEN (Secondary Education around Early Neurodevelopment) project was commissioned and funded by KindredSquared and is part of a wider drive to increase public understanding of how early experiences can shape the adults we become.

Evaluating risk to people with epilepsy during the COVID-19 pandemic - study wins international prize

In May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.

Oxfordshire Young People Involved in Childline Research Project

New research conducted by the Neuroscience, Ethics and Society group and NeurOX Young People’s Advisory Group in the Department of Psychiatry at the University of Oxford, and the NSPCC, has looked at how Childline’s message boards help support young people.

New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases

Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.

28th British Isles Research Workshop on Suicide and Self-Harm & Lancet Psychiatry Suicide Symposium

This year's annual meeting focused again on research related to the impact of the COVID-19 pandemic on suicide and self-harm. There was another session on online safety in the context of suicidal behaviour and the Online Safety Bill. Organised by the Centre for Suicide Research, University of Oxford, these virtual workshops for both senior and early career researchers from the UK and Ireland provide an important opportunity to share knowledge and discuss the latest research. This year there were also contributions from Australia and Denmark.